Pegfilgrastim PBPC Mobilization Study

Clinical trial NCT00066092 · COMPLETED

Trial details

NCT number: NCT00066092
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Hematology Oncology

Start date: 2003-04-01
Primary completion: 2004-03-01
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.